# Entegris, Inc. (ENTG)

> Source: Nexqual · https://nexqual.com/ENTG · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Entegris, Inc. (ENTG), nexqual.com/ENTG" · informational, not investment advice.

**Price:** USD 128.31 (-13.12% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 147.69 · day 127.07–141.83 · 52w 67.97–186.94 · market cap $19.6B · NMS

## Key facts
- Last four reported quarters (through Jun 27, 2026): revenue $3.33B, net income $306M (9.2% margin), free cash flow $575M (SEC filings).
- Valuation: P/E 64.2x (avg 68.6x at the last 3 fiscal year-ends), EV/EBITDA 32.2x, net debt $3.10B.
- 6 of 80 tracked superinvestors hold ENTG (13F, Q2 2026): 0 new, 1 added, 5 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 13 Form 4 filings, $16.5M; 6 not under a Rule 10b5-1 plan ($5.3M); 0 by opportunistic insiders, 2 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.13 on a 1–5 scale) (15 analysts), mean target USD 179.93 (range 120–212).
- Total return with dividends: 1Y +41.9% vs S&P 500 +14.9%; 5Y -4.7% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 1.02, revenue estimate $925M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $2.30B | $3.28B | $3.52B | $3.24B | $3.20B | $3.33B |
| Gross profit | $1.06B | $1.40B | $1.50B | $1.49B | $1.42B | — |
| Operating income | $552M | $480M | $499M | $534M | $456M | $534M |
| Net income | $409M | $209M | $181M | $293M | $236M | $306M |
| EPS (diluted) | $3.00 | $1.46 | $1.20 | $1.93 | $1.55 | — |
| Free cash flow | $190M | -$103M | $188M | $316M | $396M | $575M |
| Gross margin | 46.1% | 42.5% | 42.5% | 45.9% | 44.4% | — |
| Operating margin | 24.0% | 14.6% | 14.2% | 16.5% | 14.3% | 16.0% |
| Net margin | 17.8% | 6.4% | 5.1% | 9.0% | 7.4% | 9.2% |
| Revenue growth | +23.6% | +42.8% | +7.4% | -8.0% | -1.4% | — |
| Cash + short-term investments | $403M | $563M | $457M | $329M | $360M | — |
| Total debt | $937M | $5.78B | $4.58B | $3.98B | $3.70B | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 27, 2026)
P/E 64.2x · P/S 5.9x · EV/EBITDA 32.2x · EV/Sales 6.8x · P/FCF 34.1x · P/B 4.7x · FCF yield 2.93% · Earnings yield 1.56% · Dividend yield (paid, TTM) 0.31% · Net debt $3.10B · EV $22.7B
P/E at fiscal year-ends: Dec 2025 54.4x, Dec 2024 51.4x, Dec 2023 100.1x.

## Superinvestors (SEC 13F-HR, Q2 2026)
6 of 80 tracked investors hold ENTG. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| William Von Mueffling | Cantillon Capital Management | 2.70% | $17.9M | Reduced -95.4% |
| Mairs & Power | Mairs & Power Funds | 2.15% | $234M | Reduced -3.1% |
| Henry Ellenbogen | Durable Capital Partners | 0.51% | $52.7M | Reduced -69.8% |
| Torray Funds |  | 0.44% | $3.2M | Added +0.3% |
| Lee Ainslie | Maverick Capital | 0.01% | $864K | Reduced -62.7% |
| First Eagle Investment | First Eagle Investment Management | <0.01% | $1.7M | Reduced -4.9% |

## Insider sales (SEC Form 4, open-market, last ~7 months)
7 of 13 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-14 | Blachier Olivier | President, Materials Solutions | 2,000 | $321K | 5.4% | Yes | Too little history (no open-market trades in 2023) |
| 2026-08-13 | Colella Joseph | SVP and General Counsel | 3,916 | $644K | 7.2% | No | Too little history (no open-market trades in 2024) |
| 2026-08-11 | Rice Susan G. | SVP, Global Human Resources | 2,062 | $308K | 3% | No | Too little history (no open-market trades in 2023) |
| 2026-06-03 | Lederer James P | Director | 3,569 | $512K | 16.3% | No | Too little history (no open-market trades in 2023) |
| 2026-05-27 | Haris Clinton M. | SVP & President, APS Division | 6,848 | $1.0M | 11.1% | Yes | Routine (sold in Feb each year 2023–2025; this trade is outside those months) |
| 2026-05-15 | Rice Susan G. | SVP, Global Human Resources | 19,893 | $2.6M | 22.4% | No | Too little history (no open-market trades in 2023) |
| 2026-05-14 | Blachier Olivier | SVP, Chief Strategy Officer | 2,000 | $280K | 5.4% | No | Too little history (no open-market trades in 2023) |
| 2026-05-14 | Colella Joseph | SVP and General Counsel | 6,326 | $887K | 11.2% | No | Too little history (no open-market trades in 2024) |
| 2026-05-14 | Haris Clinton M. | SVP & President, APS Division | 5,830 | $843K | 9.6% | Yes | Routine (sold in Feb each year 2023–2025; this trade is outside those months) |
| 2026-04-17 | Loy Bertrand | Executive Chair | 44,138 | $6.4M | 16.2% | Yes | Too little history (no open-market trades in 2023) |
| 2026-04-14 | Loy Bertrand | Executive Chair | 17,396 | $2.4M | 7.1% | Yes | Too little history (no open-market trades in 2023) |
| 2026-04-07 | Blachier Olivier | SVP, Chief Strategy Officer | 275 | $32K | 0.8% | Yes | Too little history (no open-market trades in 2023) |
| 2026-04-07 | Colella Joseph | SVP and General Counsel | 1,592 | $184K | 3.1% | Yes | Too little history (no open-market trades in 2024) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Buy (mean 2.13 on a 1–5 scale), 15 analysts; mean target USD 179.93 (low 120, high 212).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-20 | Citigroup | Target raised | Buy | $170 → $195 |
| 2026-10-14 | Truist Securities | Initiated | Buy | $190 |
| 2026-10-13 | Barclays | Initiated | Overweight | $212 |
| 2026-10-08 | Stifel | Initiated | Buy | $200 |
| 2026-08-12 | Deutsche Bank | Upgrade | Hold → Buy | $152 → $200 |
| 2026-08-05 | UBS | Target raised | Buy | $205 → $215 |
| 2026-08-05 | Oppenheimer | Upgrade | Perform → Outperform | $160 → $180 |
| 2026-08-05 | Needham | Target raised | Buy | $165 → $170 |
| 2026-07-06 | Deutsche Bank | Target raised | Hold | $145 → $155 |
| 2026-07-06 | BMO Capital | Target raised | Outperform | $153 → $167 |
| 2026-07-01 | Mizuho | Target raised | Outperform | $180 → $200 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +41.9% | -4.7% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +42.0% | -1.0% |
| Volatility (annualized) | 68.5% | 52.2% |
| Max drawdown | -41.8% (Jun 2026→Jul 2026) | -58.3% (Nov 2021→Oct 2022) |

## Peers (Semiconductor Equipment & Materials)
Q (Qnity Electronics, Inc.) USD 108.78 -9.48% · NVMI (Nova Ltd.) USD 310.13 -6.37% · ONTO (Onto Innovation Inc.) USD 198.67 -10.57% · AMKR (Amkor Technology, Inc.) USD 39.05 -10.70% · TER (Teradyne, Inc.) USD 308.75 -10.63% · FORM (FormFactor, Inc.) USD 95.03 -15.29%

## More
Full page: https://nexqual.com/ENTG · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in ENTG's own 10-K filed 2026-02-11 (https://www.sec.gov/Archives/edgar/data/1101302/000110130226000012/entg-20251231.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | Nature of Operations Entegris | "Nature of Operations Entegris, Inc. ("Entegris", the "Company", "we", or "our") is a leading supplier of advanced materials and process solutions for the semiconductor and other high-technology industries." |
| Partner | QED Technologies International | "During 2023 and 2024, we completed the divestitures of QED, our EC business and our PIM business and terminated the Alliance Agreement with MacDermid Enthone." |

## Revenue by business segment (quarter ended 2026-06-27)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| APS | $514.6M | 58.3% | +17.0% |
| MS | $371.3M | 42.0% | +4.6% |
| Total revenue | $883.2M | 100% | — |

## Revenue by product line (quarter ended 2026-06-27)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Fabs | $523.3M | 59.3% | +7.0% |
| Equipment and Engineering | $167.4M | 19.0% | +40.1% |
| Chemical and Materials | $90.5M | 10.2% | +17.7% |
| Semi Distributor and Other | $59.1M | 6.7% | -10.2% |
| Non-Semi | $42.9M | 4.9% | +4.4% |
| Total revenue | $883.2M | 100% | — |

## Revenue by region (quarter ended 2026-06-27)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Taiwan | $225.4M | 25.5% | +28.7% |
| China | $168.8M | 19.1% | +2.3% |
| North America | $151.6M | 17.2% | +5.4% |
| South Korea | $114.9M | 13.0% | +6.3% |
| Japan | $91.8M | 10.4% | +11.5% |
| Southeast Asia | $70.4M | 8.0% | +16.6% |
| Europe | $60.3M | 6.8% | +4.9% |
| Total revenue | $883.2M | 100% | — |

## Company outlook (8-K filed 2026-08-04)

- "For the Company's guidance for the third quarter ending September 26, 2026, the Company expects sales of $905 million to $935 million."
- "The Company expects GAAP net income to be between $116 million and $128 million and diluted earnings per common share is expected to be between $0.75 and $0.83."
- "On a non-GAAP basis, the Company expects diluted earnings per common share to range from $0.96 to $1.04, reflecting net income on a non-GAAP basis in the range of $148 million to $160 million."
- "The Company also expects Adjusted EBITDA of approximately 28.0% to 29.0% of sales."

Analysts expect $925.3M for the current quarter, +0.6% vs the guidance midpoint $920.0M. Source: https://www.sec.gov/Archives/edgar/data/1101302/000110130226000146/entgq22026ex991.htm

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $1.02 | $0.94 | +9.4% | $925.3M | 14 |
| Next quarter (ends 2026-12-31) | $1.11 | $1.04 | +6.7% | $958.7M | 14 |
| Current fiscal year (ends 2026-12-31) | $3.93 | $3.67 | +7.3% | $3.58B | 15 |
| Next fiscal year (ends 2027-12-31) | $5.09 | $4.67 | +9.1% | $4.05B | 15 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-10-29): ±19.1%; last 8 reports averaged ±8.2%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 84.3% | ±19.1% |
| 2026-12-18 | 56 | 70.8% | ±22.5% |
| 2027-01-15 | 84 | 66.6% | ±25.7% |
| 2027-02-19 | 119 | 65.8% | ±30.1% |
| 2027-05-21 | 210 | 63.8% | ±38.4% |